These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28435061)

  • 41. Targeting apoptosis pathways in cancer stem cells.
    Signore M; Ricci-Vitiani L; De Maria R
    Cancer Lett; 2013 May; 332(2):374-82. PubMed ID: 21315505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
    Singh VK; Saini A; Chandra R
    Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implications of cancer stem cells in the treatment of cancer.
    Pan CX; Zhu W; Cheng L
    Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
    Januchowski R; Wojtowicz K; Zabel M
    Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy".
    Fiorillo M; Verre AF; Iliut M; Peiris-Pagés M; Ozsvari B; Gandara R; Cappello AR; Sotgia F; Vijayaraghavan A; Lisanti MP
    Oncotarget; 2015 Feb; 6(6):3553-62. PubMed ID: 25708684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The concept and significance of cancer stem cells].
    Haraguchi N; ishii H; Sakai D; Satoh T; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):204-9. PubMed ID: 22582581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells.
    Rezayatmand H; Razmkhah M; Razeghian-Jahromi I
    Stem Cell Res Ther; 2022 May; 13(1):181. PubMed ID: 35505363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer stem cells: in the line of fire.
    Alison MR; Lin WR; Lim SM; Nicholson LJ
    Cancer Treat Rev; 2012 Oct; 38(6):589-98. PubMed ID: 22469558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review).
    Baek SJ; Ishii H; Tamari K; Hayashi K; Nishida N; Konno M; Kawamoto K; Koseki J; Fukusumi T; Hasegawa S; Ogawa H; Hamabe A; Miyo M; Noguchi K; Seo Y; Doki Y; Mori M; Ogawa K
    Oncol Rep; 2015 Nov; 34(5):2233-7. PubMed ID: 26330103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted Drug Delivery to Cancer Stem Cells through Nanotechnological Approaches.
    Sun W; Chen G; Du F; Li X
    Curr Stem Cell Res Ther; 2021; 16(4):367-384. PubMed ID: 33023455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective killing of cancer stem cells by a novel dual-targeting strategy.
    Lou D; Wang B; Wang Y; Cao Y
    Med Hypotheses; 2012 Oct; 79(4):430-2. PubMed ID: 22818853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting CD133 antigen in cancer.
    Ferrandina G; Petrillo M; Bonanno G; Scambia G
    Expert Opin Ther Targets; 2009 Jul; 13(7):823-37. PubMed ID: 19530986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cells and differentiation therapy.
    Jin X; Jin X; Kim H
    Tumour Biol; 2017 Oct; 39(10):1010428317729933. PubMed ID: 29072131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
    Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
    Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting cancer stem cells in solid tumors by vitamin D.
    So JY; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.
    Osaki M; Okada F; Ochiya T
    Ther Deliv; 2015 Mar; 6(3):323-37. PubMed ID: 25853308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.